Vertical versus horizontal mesh-mediated fascial traction for fascial closure in open abdomen therapy – a registry-based case-control study.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00037753

Enrollment

1119

Registered

2026-06-02

Start date

2025-02-01

Completion date

Unknown

Last updated

2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Open Abdomen K65 R19.8

Interventions

Group 1: VMMFT cohort: Patients undergoing open abdomen therapy who were treated with vertical mesh-mediated fascial traction (VMMFT) using a vertical traction device (e.g., Fasciotens® Abdomen), typi

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients undergoing open abdomen therapy (OAT) Use of active fascial traction by either vacuum-assisted wound closure with mesh-mediated fascial traction (VAWCM) or vertical mesh-mediated fascial traction (VMMFT) Documentation within the European Hernia Society (EHS) Open Abdomen Registry Availability of relevant baseline and outcome parameters required for analysis

Exclusion criteria

Exclusion criteria: Missing documentation of the applied fascial traction technique Missing data regarding matching variables or primary outcome parameters Cases without documented course of fascial closure management Duplicate registry entries

Design outcomes

Primary

Measure	Time frame
Rate of definitive fascial closure (DFC) at the end of open abdomen therapy. Definitive fascial closure is defined as complete closure of the abdominal fascia without a remaining fascial defect at the end of open abdomen treatment.	—

Secondary

Measure	Time frame
In-hospital mortality Death occurring during the hospital stay after initiation of open abdomen therapy. Occurrence of enteroatmospheric fistula Development of an intestinal fistula with direct communication to the open abdomen during therapy. Duration of open abdomen therapy (OAT) Time between initiation of open abdomen therapy and definitive fascial closure or termination of OAT. ICU length of stay Number of days spent in the intensive care unit during hospitalization. Duration of mechanical ventilation Total duration of invasive mechanical ventilation during hospitalization (hours). Total hospital length of stay Number of days from admission until discharge or death. Horizontal fascial defect width at the end of OAT Distance between fascial edges measured in centimeters at the end of therapy. Björck classification at the end of OAT Classification of the abdominal condition (e.g., contamination, fistula, adhesions) according to the Björck classification.	—

Measure

Time frame

In-hospital mortality Death occurring during the hospital stay after initiation of open abdomen therapy. Occurrence of enteroatmospheric fistula Development of an intestinal fistula with direct communication to the open abdomen during therapy. Duration of open abdomen therapy (OAT) Time between initiation of open abdomen therapy and definitive fascial closure or termination of OAT. ICU length of stay Number of days spent in the intensive care unit during hospitalization. Duration of mechanical ventilation Total duration of invasive mechanical ventilation during hospitalization (hours). Total hospital length of stay Number of days from admission until discharge or death. Horizontal fascial defect width at the end of OAT Distance between fascial edges measured in centimeters at the end of therapy. Björck classification at the end of OAT Classification of the abdominal condition (e.g., contamination, fistula, adhesions) according to the Björck classification.

—

Countries

Germany

Contacts

Public ContactSebastian Schaaf

Bundeswehrzentralkrankenhaus Koblenz

sebastianschaaf@bundeswehr.org+4926128122810

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 29, 2026